These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 18322971
1. Lessons from magnetic resonance imaging studies in rheumatoid arthritis. Quinn M. J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971 [No Abstract] [Full Text] [Related]
2. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks. Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J. J Rheumatol; 2008 Mar; 35(3):394-7. PubMed ID: 18203329 [Abstract] [Full Text] [Related]
5. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. Kamishima T, Kato M, Atsumi T, Koike T, Onodera Y, Terae S. Clin Exp Rheumatol; 2013 Mar; 31(1):154. PubMed ID: 23190694 [No Abstract] [Full Text] [Related]
6. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B, Baird AN, Hanson RR, Wright JM, Lin HC, Purohit RC. Am J Vet Res; 1996 Jul; 57(7):1080-93. PubMed ID: 8807026 [Abstract] [Full Text] [Related]
10. How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Schett G, Stach C, Zwerina J, Voll R, Manger B. Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703 [No Abstract] [Full Text] [Related]
11. Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality? van den Berg WB, van Riel PL. Arthritis Rheum; 2005 Apr; 52(4):995-9. PubMed ID: 15818666 [No Abstract] [Full Text] [Related]
12. [Histopathological features of joint destruction in rheumatoid arthritis (RA)]. Uzuki M, Sawai T, Sasaki Y. Clin Calcium; 2007 Apr; 17(4):474-83. PubMed ID: 17404475 [Abstract] [Full Text] [Related]
13. Treatment of periodontoid pannus with infliximab in a patient with rheumatoid arthritis. Salli A, Sahin N, Paksoy Y, Kucuksarac S, Ugurlu H. J Clin Rheumatol; 2009 Aug; 15(5):250-1. PubMed ID: 19590438 [No Abstract] [Full Text] [Related]
14. Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al. Fautrel B, Foltz V, Frances C, Bourgeois P, Rozenberg S. Arthritis Rheum; 2002 May; 46(5):1408-9; author reply 1409. PubMed ID: 12115253 [No Abstract] [Full Text] [Related]
15. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials. Gerlag DM, Tak PP. Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687 [Abstract] [Full Text] [Related]
16. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Šenolt L, Kuklová M, Cerezo LA, Hulejová H, Filková M, Bošanská L, Pecha O, Pavelka K, Haluzík M, Vencovský J. Ann Rheum Dis; 2011 Nov; 70(11):2054-6. PubMed ID: 21622768 [No Abstract] [Full Text] [Related]
17. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Kruithof E, De Rycke L, Roth J, Mielants H, Van den Bosch F, De Keyser F, Veys EM, Baeten D. Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106 [Abstract] [Full Text] [Related]
18. Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: comment on the article by Sokka and Pincus. Estrach C, Mpofu S, Thompson RN, Williams E, Abernethy VE, Moots RJ. Arthritis Rheum; 2003 Dec; 48(12):3611-3; author reply 3613-5. PubMed ID: 14674016 [No Abstract] [Full Text] [Related]
19. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)]. Kaliterna DM. Reumatizam; 2008 Dec; 55(2):60-1. PubMed ID: 19024277 [Abstract] [Full Text] [Related]
20. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Polzer K, Baeten D, Soleiman A, Distler J, Gerlag DM, Tak PP, Schett G, Zwerina J. Ann Rheum Dis; 2008 Nov; 67(11):1610-6. PubMed ID: 18174217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]